Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Doherty

Showing results (21-30 of 211) with videos related to

Pageof 22
Sort By:
JCO Clinical Cancer Informatics|November 23, 2019
Feasibility of Capturing Cancer Treatment Data in the Utah All-Payer Claims DatabaseMia Hashibe, Judy Y Ou, Kimberly Herget, et al.
American Journal of Epidemiology|December 12, 2007
Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factorsBabette S Saltzman, Jennifer A Doherty, Deirdre A Hill, et al.
International Journal of Cancer|December 7, 2005
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and the risk of fibrocystic breast conditions among Chinese womenChu Chen, Jennifer A Doherty, S Kay Lewis, et al.
Cancer Causes & Control : CCC|July 8, 2021
Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancerLaurie Grieshober, Stefan Graw, Matt J Barnett, et al.
Journal of Cancer Survivorship : Research and Practice|June 5, 2025
Factors associated with cancer-related pain among Utah cancer survivorsRachel R Codden, Blessing S Ofori-Atta, Marjorie E Carter, et al.
Genome Biology|October 20, 2023
Performance of computational algorithms to deconvolve heterogeneous bulk ovarian tumor tissue depends on experimental factorsAriel A Hippen, Dalia K Omran, Lukas M Weber, et al.
Endocrinology, Diabetes & Metabolism|June 5, 2023
Metabolic obesity phenotypes and obesity-related cancer risk in the National Health and Nutrition Examination SurveyMaci Winn, Prasoona Karra, Heinz Freisling, et al.
American Journal of Obstetrics and Gynecology|June 26, 2012
Biomarkers of progestin therapy resistance and endometrial hyperplasia progressionKristen Upson, Kimberly H Allison, Susan D Reed, et al.
Cancer Medicine|June 20, 2022
Metabolic dysfunction and obesity-related cancer: Results from the cross-sectional National Health and Nutrition Examination SurveyMaci Winn, Prasoona Karra, Benjamin Haaland, et al.
Journal of the National Cancer Institute|May 3, 2018
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease StageLauren C Peres, Kara L Cushing-Haugen, Martin Köbel, et al.
Pageof 22

Showing results (21-30 of 211) with videos related to

Sort By:
Pageof 22
JCO Clinical Cancer Informatics|November 23, 2019
Feasibility of Capturing Cancer Treatment Data in the Utah All-Payer Claims DatabaseMia Hashibe, Judy Y Ou, Kimberly Herget, et al.
American Journal of Epidemiology|December 12, 2007
Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factorsBabette S Saltzman, Jennifer A Doherty, Deirdre A Hill, et al.
International Journal of Cancer|December 7, 2005
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and the risk of fibrocystic breast conditions among Chinese womenChu Chen, Jennifer A Doherty, S Kay Lewis, et al.
Cancer Causes & Control : CCC|July 8, 2021
Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancerLaurie Grieshober, Stefan Graw, Matt J Barnett, et al.
Journal of Cancer Survivorship : Research and Practice|June 5, 2025
Factors associated with cancer-related pain among Utah cancer survivorsRachel R Codden, Blessing S Ofori-Atta, Marjorie E Carter, et al.
Genome Biology|October 20, 2023
Performance of computational algorithms to deconvolve heterogeneous bulk ovarian tumor tissue depends on experimental factorsAriel A Hippen, Dalia K Omran, Lukas M Weber, et al.
Endocrinology, Diabetes & Metabolism|June 5, 2023
Metabolic obesity phenotypes and obesity-related cancer risk in the National Health and Nutrition Examination SurveyMaci Winn, Prasoona Karra, Heinz Freisling, et al.
American Journal of Obstetrics and Gynecology|June 26, 2012
Biomarkers of progestin therapy resistance and endometrial hyperplasia progressionKristen Upson, Kimberly H Allison, Susan D Reed, et al.
Cancer Medicine|June 20, 2022
Metabolic dysfunction and obesity-related cancer: Results from the cross-sectional National Health and Nutrition Examination SurveyMaci Winn, Prasoona Karra, Benjamin Haaland, et al.
Journal of the National Cancer Institute|May 3, 2018
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease StageLauren C Peres, Kara L Cushing-Haugen, Martin Köbel, et al.
Pageof 22